PITTSBURGH, Jan. 29, 2026 /PRNewswire/ - MolecuLight today announced that its MolecuLightDX® wound measurement has been qualified by the U.S. Food and Drug Administration (FDA) as a Medical Device ...
Designation highlights GeneDx innovation in clinical whole genome and whole exome testing and accelerates the pathway for FDA authorization of these novel diagnostic tests With more than 2.5 million ...
The software is designed to analyze digital pathology whole-slide images of skin lesions and aid pathologists in their review.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results